Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide.
The ruthenium arene anticancer complex [(eta(6)-bip)Ru(en)Cl][PF(6)] (1) (bip is biphenyl, en is ethylenediamine) reacted slowly with the amino acid L-histidine (L-His) in aqueous solution at 310 K. Two L-His adducts of 1 were separated by high-performance liquid chromatography and identified by electrospray ionisation mass spectrometry and NMR: an imidazole N(delta)-bound complex [(eta(6)-bip)Ru(en)(N(delta)-L-His)](2+), and an N(epsilon)-bound complex [(eta(6)-bip)Ru(en)(N(epsilon)-L-His)](2+). At 310 K, after 24 h only about 22% of complex 1 (2 mM) reacted with L-His, and of the unreacted 1, 59% had hydrolysed. In the presence of 100 mM NaCl, approximately 90% of 1 remained unreacted. In aqueous solution or triethylammonium acetate (TEAA) buffer (pH 7.6), (15)N-labelled 1 reacted with cytochrome c to give two monoruthenated protein adducts. The reaction reached equilibrium within 2 h by which time approximately 50% of cytochrome c was ruthenated. On the basis of [(1)H, (15)N] NMR data, one adduct may have Ru bound to the N-terminus, and the other to a carboxylate group on the protein. In TEAA buffer and at 310 K, more than 90% of the 14-mer oligonucleotide d(TATGTACCATGTAT) reacted with 2 mol Eq of 1 to give rise to monoruthenated and diruthenated oligonucleotide adducts. The presence of cytochrome c (1 mol Eq) or L-His (4 mol Eq) had little effect on the course of the reaction with the oligonucleotide. In cells, DNA (or RNA) may be a favoured reaction site for this Ru anticancer complex.
Wang
Fuyi
F
School of Chemistry, University of Edinburgh, UK.
Bella
Juraj
J
Parkinson
John A
JA
Sadler
Peter J
PJ
D000970:Antineoplastic Agents / Q000737:chemistry*; D001483:Base Sequence; D001667:Binding, Competitive; D045304:Cytochromes c / Q000737:chemistry*; D006639:Histidine / Q000737:chemistry*; D015394:Molecular Structure; D009838:Oligodeoxyribonucleotides / Q000737:chemistry*; D011485:Protein Binding; D017975:Ruthenium Compounds / Q000737:chemistry*
D000970:Antineoplastic Agents; D009838:Oligodeoxyribonucleotides; D017975:Ruthenium Compounds; D006639:Histidine; D045304:Cytochromes c
J Med Chem. 2001 Oct 25;44(22):3616-21
11606126
J Am Chem Soc. 2003 Jan 8;125(1):173-86
12515520
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3838-40
12646702
Chemistry. 2003 Dec 5;9(23):5810-20
14673852
Br J Cancer. 2002 May 20;86(10):1652-7
12085218
Spectrochim Acta A Mol Biomol Spectrosc. 2000 Dec;56(14):2699-705
11145336
J Biomol NMR. 1994 Mar;4(2):301-6
8019138
J Biol Chem. 1994 Jan 28;269(4):2581-8
8300587
Chem Rev. 1999 Sep 8;99(9):2499-510
11749488
J Mol Biol. 1990 Jul 20;214(2):585-95
2166170
Inorg Chem. 1996 Feb 14;35(4):1065-1072
11666286
Chem Commun (Camb). 2004 Aug 21;(16):1786-7
15306883
Inorg Chem. 2002 Aug 26;41(17):4509-23
12184769
J Am Chem Soc. 2002 Mar 27;124(12):3064-82
11902898